We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-2.54%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$49.4B
AUM Growth
-$1.83B
Cap. Flow
+$236M
Cap. Flow %
0.48%
Top 10 Hldgs %
23.11%
Holding
2,899
New
506
Increased
652
Reduced
806
Closed
772

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.93B
2
KVUE icon
Kenvue
KVUE
+$537M
3
HUM icon
Humana
HUM
+$477M
4
ABBV icon
AbbVie
ABBV
+$441M
5
MSFT icon
Microsoft
MSFT
+$384M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$747M
2
AAPL icon
Apple
AAPL
+$565M
3
ATVI
Activision Blizzard
ATVI
+$467M
4
MCK icon
McKesson
MCK
+$347M
5
INTC icon
Intel
INTC
+$300M

Sector Composition

Rank Sector Weight
1 Technology 19.79%
2 Healthcare 17.06%
3 Consumer Discretionary 12.96%
4 Consumer Staples 7.45%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CANO
2801
DELISTED
Cano Health, Inc.
CANO
– –
-289
Closed -$40.2K
FRBN
2802
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
– –
-209,655
Closed -$2.25M
SKIL.WS
2803
CALL
DELISTED
Skillsoft Corp. Warrants, each whole warrant is exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SKIL.WS
– –
-335,816
Closed -$416K
FZT.WS
2804
CALL
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
– –
-140,000
Closed -$1.47M
SYNH
2805
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-86,800
Closed -$3.66M
SLVR
2806
DELISTED
SilverSPAC Inc. Class A Ordinary Share
SLVR
– –
-14,577
Closed -$151K
ICNC.WS
2807
CALL
DELISTED
Iconic Sports Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ICNC.WS
– –
-787,857
Closed -$8.39M
RETA
2808
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-84,508
Closed -$8.62M
GFGDR
2809
CALL
DELISTED
The Growth for Good Acquisition Corporation Right
GFGDR
– –
-327,169
Closed -$3.42M
GFGDW
2810
CALL
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
– –
-163,584
Closed -$1.71M
ADERW
2811
CALL
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
– –
-335,990
Closed -$3.62M
RADI
2812
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
– –
-97,900
Closed -$1.46M
CHEAW
2813
CALL
DELISTED
Chenghe Acquisition Co. Warrant
CHEAW
– –
-17,287
Closed -$185K
MBSC
2814
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
– –
-251,511
Closed -$2.63M
MBSC.WS
2815
CALL
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
– –
-83,016
Closed -$871K
PIAI.WS
2816
CALL
DELISTED
Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PIAI.WS
– –
-192,554
Closed -$2.05M
WWE
2817
DELISTED
World Wrestling Entertainment
WWE
– –
-323,900
Closed -$35.1M
QUOT
2818
DELISTED
Quotient Technology Inc
QUOT
– –
-155,900
Closed -$599K
BKI
2819
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-1,034,041
Closed -$61.8M
ROIVW
2820
CALL
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
– –
-483,165
Closed -$4.87M
NUVA
2821
DELISTED
NuVasive, Inc.
NUVA
– –
-279,310
Closed -$11.6M
CCAIW
2822
CALL
DELISTED
Cascadia Acquisition Corp. Warrant
CCAIW
– –
-115,140
Closed -$1.33M
FOCS
2823
DELISTED
Focus Financial Partners Inc. Class A
FOCS
– –
-155,771
Closed -$8.18M
FXLV
2824
DELISTED
F45 Training Holdings Inc.
FXLV
– –
-88,004
Closed -$44K
WAVC.WS
2825
CALL
DELISTED
Waverley Capital Acquisition Corp. 1 Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
WAVC.WS
– –
-135,095
Closed -$1.4M
111 112
113
114 115

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q3 2023 Portfolio in Review

As of Q3 2023, Marshall Wace held 2,899 positions worth $49.4B, down 3.6% from $51.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Marshall Wace's Q3 2023 filing shows 506 new, 652 increased, 806 reduced and 772 closed positions. Its largest new stake was Humana: 1,014,185 shares worth $493M. The largest sale was Amazon, an estimated $747M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q3 2023 buy was Humana: 1,014,185 shares worth $493M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $1.93B increase.
  • Marshall Wace's biggest Q3 2023 reduction was Amazon, cutting an estimated $747M.
  • Marshall Wace fully exited Johnson & Johnson in Q3 2023, selling an estimated $284M.
  • Marshall Wace's ten largest holdings make up 23% of its $49.4B portfolio in Q3 2023.
  • Marshall Wace opened 506 new positions and closed 772 in Q3 2023.
  • Marshall Wace's portfolio value fell 3.6% quarter-over-quarter to $49.4B.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.